Related Experiment Video

Updated: May 16, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Anti-tumor immunity, autophagy and chemotherapy

Györgyi Műzes1, Ferenc Sipos

  • 12nd Department of Internal Medicine, Semmelweis University, 1088 Budapest, Hungary. muzes.gyorgyi@med.semmelweis-univ.hu

World Journal of Gastroenterology
|December 14, 2012
PubMed

Insights

Autophagy, a cellular self-digestion process, plays a dual role in cancer, potentially promoting survival and resistance, or acting as a tumor suppressor. Its precise impact depends on various cellular and environmental factors, offering new avenues for cancer therapy.

Area of Science:

  • Cellular biology
  • Oncology
  • Cancer research

Background:

  • Autophagy (self-digestion) is activated by stress and linked to cancer survival and drug resistance.
  • Genetic studies suggest autophagy can also function as a tumor suppressor.
  • Defective autophagy is implicated in the development of tumors.

Purpose of the Study:

  • To clarify the complex and context-dependent role of autophagy in malignant transformation.
  • To explore the relationship between autophagy and anticancer immune responses for novel therapeutic strategies.

Main Methods:

  • Review of genetic studies and recent data on autophagy.
  • Analysis of factors influencing autophagy's role in cancer (cell type, phase, genetics, microenvironment).

Main Results:

  • Autophagy's impact on cancer is multifaceted and not fully understood.
  • Its role is significantly influenced by cell-specific, genetic, and microenvironmental contexts.
  • Autophagy's connection to anticancer immunity presents a promising area for research.

Conclusions:

  • Autophagy's role in cancer is complex, acting as both a promoter and suppressor.
  • Understanding these dynamics is crucial for developing effective cancer treatments.
  • The interplay between autophagy and the immune system offers potential for novel cancer chemotherapy approaches.
Keywords:
Antitumor immunityAutophagyCancerCell deathChemotherapy

More Related Videos

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...